Who is the CEO of EWTX? | Glauxie AI

Q: Who is the CEO of EWTX?

Edgewise Therapeutics, Inc. (EWTX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Kevin Koch. Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered... Employees: 35,000.

Q: What does EWTX company do?

Learn what EWTX does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling EWTX?

Track recent insider buys and sells for EWTX with transaction details, amounts, and trends.

Q: What sector is EWTX in?

Find EWTX sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of EWTX?

🦉

Edgewise Therapeutics, Inc. (EWTX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOKevin Koch

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular...

Key Executives

Name	Title
Alan J. Russell	Co-Founder, Chief Scientific Officer & Director
Badreddin Edris	Co-Founder & Independent Director
Behrad Derakhshan	Chief Operating Officer
Joanne Donovan	Chief Medical Officer
John R. Moore	General Counsel
Kevin Koch	President, Chief Executive Officer & Director

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

EWTX Profile Financials

What does EWTX company do? Are insiders buying or selling EWTX? What sector is EWTX in?